Sun Pharma to acquire Japan’s Pola Pharma for $1 million

Sun Pharma to acquire Japan’s Pola Pharma for $1 million

Sun Pharma Monday said it has entered into a definitive agreement to acquire Japan-based Pola Pharma for around $1 million to strengthen its global dermatology presence. Pola Pharma, is engaged in research and development, manufacture, sale and distribution of branded and generic products in Japan. Sun Pharma will acquire 100% in Pola Pharma for equity consideration. Pola Pharma had an annual revenue of around $108 million and net loss of $7 million for the 12 months ended December 2017 on consolidated basis.

Read More at Livemint News date : 26 Nov 2018, Monday

©2018 TheNewsClues